Repositorio Dspace

Envíos recientes

02.06.01. Investigación y comunicación científica: Envíos recientes

  • First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN 
    Martínez-Jánez, N; Bellet-Ezquerra, M; Sánchez-Mansó, LM; Henao-Carrasco, F; Antón-Torres, A; Morales, S; Tolosa-Ortega, P; Obadía-Gil, VL; Sampedro, T; Andrés-Conejero, R; Calvo-Martínez, L; Galve-Calvo, E; López, R; Ayala-de-la-Peña, Francisco; López-Tarruella, S; Hernando-Fernández-de-Araguiz, BA; Boronat-Ruiz, L; Martos-Cárdenas, T; Chacón, JI; Antón, FMoreno (Springer, 2024-07)
    PURPOSE: To evaluate the efficacy and safety of first-line therapy with palbociclib in a Spanish cohort treated after palbociclib approval. METHODS: PALBOSPAIN is an observational, retrospective, multicenter study evaluating ...
  • Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis 
    Mosquera-Orgueira, Adrián; Arellano-Rodrigo, Eduardo; Garrote, Marta; Martín, Iván; Pérez-Encinas, Manuel-Mateo; Gómez-Casares, María-Teresa; Hernández-Sánchez, Alberto; Ferrer-Marín, Francisca; Mora, Elvira; Vélez, Patricia; Ayala, Rosa; Angona, Anna; de-las-Heras, Natalia; Magro, Elena; Pérez-Míguez, Carlos; Crucitti, Davide; Mata-Vázquez, María-Isabel; Fox, María-Laura; González-de-Villambrosía, Sonia; Ramírez, María-José; García, Ana; García-Gutiérrez, Valentín; Cáceres, Amparo; Durán, María-Antonia; Senín, María-Alicia; Raya, José-María; González, José-A; Cuevas, Beatriz; Xicoy, Blanca; Nangalia, Jyoti; Hernández-Rivas, Jesús-María; Bellosillo, Beatriz; Álvarez-Larrán, Alberto; Hernández-Boluda, Juan-Carlos (John Wiley And Sons Inc, 2024)
    OBJECTIVE: To analyze the influence of the resting interval after removal of a double-balloon for cervical ripening and oxytocin administration on the time to onset of active labor in singleton pregnancies. METHODS: A ...
  • Effect of the SARS-CoV-2 pandemic on colorectal cancer diagnosis and prognosis 
    Medina-Prado, Lucía; Sala-Miquel, Noelia; Aicart-Ramos, Marta; López-Cardona, Julia; Ponce-Romero, Marta; Ortiz, Oswaldo; Pellise, María; Aguilera, Lara; Díez-Redondo, Pilar; Núñez-Rodríguez, Henar; Seoane, Agustín; Domper-Arnal, María-José; Borao-Laguna, Cristina; González-Bernardo, Óscar; Suárez, Adolfo; Muñoz-Tornero, María; Bustamante-Balen, Marco; Soutullo-Castineiras, Carlos; Balleste-Peris, Belén; Esteban, Pilar; Jiménez-Gómez, Mirella; Albert, Marc; Lucas, Javier; Valdivieso-Cortazar, Eduardo; López-Serrano, Antonio; Solano, Marina; Tejedor-Tejada, Javier; Trelles, Marita; Zapater, Pedro; Jover, Rodrigo (Wiley, 2024-03)
    BACKGROUND AND STUDY AIMS: Our aim was to determine the impact of the SARS-CoV-2 pandemic on the diagnosis and prognosis of colorectal cancer (CRC). PATIENTS AND METHODS: This prospective cohort study included individuals ...
  • Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes 
    García-Torralba, Esmeralda; Pérez-Ramos, Miguel; Ivars-Rubio, Alejandra; Navarro-Manzano, Esther; Blaya-Boluda, Noel; Lloret-Gil, Miguel; Aller, Alberto; de-la-Morena-Barrio, Pilar; García-Garre, Elisa; Martínez-Díaz, Francisco; García-Molina, Francisco; Chaves-Benito, Asunción; García-Martínez, Elena; Ayala-de-la-Peña, Francisco (Springer, 2024-06)
    PURPOSE: The prognostic utility and biological correlates of neutrophil to lymphocyte ratio (NLR), a potential biomarker of the balance between immune response and the inflammatory status, are still uncertain in breast ...
  • Comparative bioactivity and immunomodulatory potential of the new Bioroot Flow and AH Plus Bioceramic sealer: An in vitro study on hPDLSCs 
    Sanz, José-Luis; López-García, Sergio; García-Bernal, David; Rodríguez-Lozano, Francisco-Javier; Forner, Leopoldo; Lozano, Adrián; Murcia, Laura (Springer Heidelberg, 2024-03)
    OBJECTIVES: To evaluate the cytocompatibility, bioactivity, and anti-inflammatory potential of the new pre-mixed calcium silicate cement-based sealers Bioroot Flow (BrF) and AH Plus Bioceramic Sealer (AHPbcs) on human ...
  • ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options 
    Kiladjian, Jean-Jacques; Ferrer-Marín, Francisca; Al-Ali, Haifa-Kathrin; Álvarez-Larrán, Alberto; Beggiato, Eloise; Bieniaszewska, María; Breccia, Massimo; Buxhofer-Ausch, Veronika; Cerna, Olga; Crisan, Ana-Manuela; Danaila, Catalin-Doru; de-Stefano, Valerio; Doehner, Konstanze; Empson, Victoria; Gora-Tybor, Joanna; Griesshammer, Martín; Grosicki, Sebastián; Guglielmelli, Paola; García-Gutiérrez, Valentín; Heidel, Florian-H; Illes, Arpad; Tomuleasa, Ciprian; James, Chloe; Koschmieder, Steffen; Krauth, María-Theresa; Krejcy, Kurt; Lázaroiu, Mihaela-Cornelia; Mayer, Jiri; Nagy, Zsolt-Gyoergy; Nicolini, Franck-Emmanuel; Palandri, Francesca; Pappa, Vassiliki; Reiter, Andreas-Johannes; Sacha, Tomász; Schlager, Stefanie; Schmidt, Stefan; Terpos, Evangelos; Unger, Martín; Woelfler, Albert; Xicoy, Blanca; Klade, Christoph (Springer, 2024-07)
    Interferon-based therapies, such as ropeginterferon alfa-2b have emerged as promising disease-modifying agents for myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET). Current ET treatments aim ...
  • Premixed calcium silicate-based ceramic sealers promote osteogenic/cementogenic differentiation of human periodontal ligament stem cells: A microscopy study 
    López-García, Sergio; Sánchez-Bautista, Sonia; García-Bernal, David; Lozano, Adrián; Forner, Leopoldo; Sanz, José-Luis; Murcia, Laura; Rodríguez-Lozano, Francisco-Javier; Oñate-Sánchez, Ricardo-Elías (Wiley, 2024-07)
    To evaluate the effects of premixed calcium silicate based ceramic sealers on the viability and osteogenic/cementogenic differentiation of human periodontal ligament stem cells (hPDLSCs). The materials evaluated were ...
  • Oral manifestations in women using hormonal contraceptive methods: a systematic review 
    García-Rojo, Marta; Pecci-Lloret, Miguel-Ramón; Guerrero-Gironés, Julia (Springer Heidelberg, 2024-03)
    OBJECTIVES: To investigate the oral manifestations in women of reproductive age using hormonal contraceptive methods. MATERIALS AND METHODS: This review is based on the PRISMA statement. A literature search incorporated ...
  • Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry 
    Arias-Martínez, Aranzazu; Martínez-de-Castro, Eva; Gallego, Javier; Arrazubi, Virginia; Custodio, Ana-Belén; Fernández-Montes, Ana; Díez, Marc; Hernández, Raquel; Limón-Mirón, María-Luisa; Cano, Juana-María; Vidal-Tocino, Rosario; Macías, Ismael; Visa, Laura; Martín-Richard, Marta; Sauri, Tamara; Hierro, Cinta; Gil, Mireia; Cerdá, Paula; Martínez-Moreno, Elia; Martínez-Lago, Nieves; Merida-García, Antonio-José; Gómez-González, Lucía; García-Navalón, Francisco-Javier; Ruiz-Martín, Maribel; Marín, Gema; López-López, Flora; Rupérez-Blanco, Ana-Belén; Fernández, Alejandro-Francisco; Jiménez-Fonseca, Paula; Carmona-Bayonas, Alberto; Álvarez-Mancenido, Felipe (Springer Int Publ Ag, 2024-07)
    BACKGROUND: The optimal chemotherapy backbone for HER2-negative advanced esophagogastric cancer, either in combination with targeted therapies or as a comparator in clinical trials, is uncertain. The subtle yet crucial ...
  • Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology 
    Garrote, Marta; López-Guerra, Mónica; García-Pagan, Juan-Carlos; Arellano-Rodrigo, Eduardo; Ferrer-Marín, Francisca; Hernández-Boluda, Juan-Carlos; Bellosillo, Beatriz; Nomdedeu, Meritxell; Hernández-Gea, Virginia; Triguero, Ana; Guijarro, Francesca; Álamo, José; Baiges, Anna; Turon, Fanny; Colomer, Dolors; Cervantes, Francisco; Álvarez-Larrán, Alberto (Springer, 2024-03)
    To elucidate the role of splanchnic vein thrombosis (SVT) and genomic characteristics in prognosis and survival, we compared patients with polycythemia vera (PV) or essential thrombocythemia (ET) presenting SVT at diagnosis ...
  • Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience 
    Sobas, Marta; Knopinska-Posluszny, Wanda; Piatkowska-Jakubas, Beata; García-Álvarez, Flor; Amutio-Díez, María-Elena; Caballero, Mar; Martínez-Cuadrón, David; Aguiar, Eliana; González-Campos, José; Garrido, Ana; Algarra, Lorenzo; Salamero, Olga; de-la-Serna, Javier; Sayas, María-José; Pérez-Encinas, Manuel-Mateo; Vives, Susana; Vidriales, Belén; Labrador, Jorge; Prado, Ana-Ines; Celebrin, Lucía; Mayer, Jiri; Brioso, Joana; de-Laiglesia, Almudena; Bergua-Burgues, Juan-Miguel; Amigo, María-Luz; Rodríguez-Medina, Carlos; Polo, Marta; Pluta, Agnieszka; Cichocka, Edyta; Skarupski, Marek; Sanz, Miguel-Ángel; Wierzbowska, Agnieszka; Montesinos, Pau (Springer, 2024-02)
    The most important challenges in acute promyelocytic leukemia (APL) is preventing early death and reducing long-term events, such as second neoplasms (s-NPLs). We performed a retrospective analysis of 2670 unselected APL ...
  • Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study 
    Meca-Lallana, José-Eustasio; Prieto-González, José-M; Caminero-Rodríguez, Ana-B; Olascoaga-Urtaza, Javier; Alonso, Ana-M; Durán-Ferreras, Eduardo; Espinosa, Raúl; Dotor, Julio; Romera, Mercedes; Ares-Luque, Adrián; Pérez-Ruiz, Domingo; Calles, Carmen; Hernández, Miguel-A; Hervás-García, Miguel; Mendoz-Rodríguez, Amelia; Montero, Yasmina-Berdei; Téllez, Nieves; Herrera-Varó, Nicolás; Sotoca, Javier; Presas-Rodríguez, Silvia; Querol-Gutiérrez, Luis; Hervás-Pujol, Mariona; Nadal, Jordi; Ozaeta, Gisela-Martín; Gubieras-Lillo, Laura; Martínez-Yélamos, Sergio; Ramio-Torrenta, Lluis; Mallada-Frechin, Javier; Belenguer-Benavides, Antonio; Gascón-Giménez, Francisco; Casanova, Bonaventura; Lamberto-Landete, Pascual; Berenguer-Ruiz, Leticia; Navarro, Laura; Gómez-Gutiérrez, Montserrat; Durán, Carmen; Rodríguez-egal, Ana; Álvarez, Elena; García-Estevez, Daniel-A; López-Real, Ana-M; González, Miguel-ALlaneza; Sola, María-EMarzo; Sánchez-Menoyo, José-L; Oterino, Agustín; Villaverde-González, Ramón; Castillo-Trivino, T; de-Arcaya, Amaya; Llarena, Cristina (Springer London Ltd, 2023-12)
    INTRODUCTION: Teriflunomide is a once-daily oral immunomodulator approved for relapsing forms of multiple sclerosis (MS) or relapsing-remitting multiple sclerosis (RRMS; depending on the local label), based on extensive ...
  • Assessment of the potential value of plasma Torque Teno virus DNA load monitoring to predict cytomegalovirus DNAemia in patients with hematological malignancies treated with small molecule inhibitors: A proof-of-concept study 
    Solano-de-la-Asunción, Carlos; Giménez, Estela; Hernández-Boluda, Juan-Carlos; Terol, María-José; Albert, Eliseo; López, Javier; García-Gutiérrez, Valentín; Andreu, Rafael; García-Malo, María-Dolores; Fox, María-Laura; Remigia, María-José; Amat, Paula; Solano, Carlos; Navarro, David (Wiley, 2023-07)
    It is unknown whether Torque Teno virus (TTV) DNA load monitoring could anticipate the development of infectious events in hematological patients undergoing treatment with small molecular targeting agents. We characterized ...
  • Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion 
    Castillo, Martín-I; Ribate, Villamon-E; Calabuig-Muñoz, M; Santillana, Sanz-G; Taboada, Such-E; Castera, Mora-E; Calasanz-Abinzano, MJ; Barranco, Irigoyen-A; Nieto, Collado-R; Pampliega, Vara-M; Blanco, ML; de-Andrés, Álvarez-S; de-Oteyza, Pérez-J; del-Castillo, Bernal-T; Font, Granada-I; Jerez-Cayuela, Andrés; Díez-Campelo, María; Sánchez, Abellan-R; Vercet, Solano-C; Díaz, Tormo-M (Wiley, 2023-08)
    BACKGROUND: In myelodysplastic neoplasms (MDS), the 20q deletion [del(20q)] is a recurrent chromosomal abnormality that it has a high co-occurrence with U2AF1 mutations. Nevertheless, the prognostic impact of U2AF1 in these ...
  • SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022) 
    Ayala-de-la-Peña, Francisco; Antolín-Novoa, Silvia; GÁvila-Gregori, Joaquín; González-Cortijo, Lucía; Henao-Carrasco, Fernando; Martínez-Martínez, María-Jesús; Morales-Estevez, Cristina; Stradella, Agostina; Vidal-Losada, María-Jesús; Ciruelos, Eva (Springer Int Publ Ag, 2023-09)
    Breast cancer is the leading cause of cancer in women in Spain and its annual incidence is rapidly increasing. Thanks to the screening programs in place, nearly 90% of breast cancer cases are detected in early and potentially ...
  • Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group 
    Sánchez-Cánovas, Manuel; Fernández-Garay, David; Gómez-Martínez, Francisco; Brozos-Vázquez, Elena; Lobo-de-Mena, Miriam; García-Adrian, Silvia; Pacheco-Barcia, Vilma; Cacho-Lavín, Diego; Martínez-de-Castro, Eva; Martín-Fernández-de-Soignie, Ana-Manuela; Martínez, Elia; Rupérez-Blanco, Ana-Belén; García-Escobar, Ignacio; Coloma, Carmen-Salvador; Blaya-Boluda, Noel; Guirao-García, María-Esperanza; Gambín-Arroniz, Mariano; Muñoz-Martín, Andrés-Jesús (Springer Int Publ Ag, 2024-01)
    PURPOSE: The CoVID-TE model was developed with the aim of predicting venous thrombotic events (VTE) in cancer patients with Sars-Cov-2 infection. Moreover, it was capable of predicting hemorrhage and mortality 30 days ...
  • Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry 
    Bernal, Teresa; Fernández-Moreno, Ainhoa; de-LaIglesia, Almudena; Benavente, Celina; García-Noblejas, Ana; García-Belmonte, Daniel; Riaza, Rosalía; Salamero, Olga; Foncillas, María-Ángeles; Roldán, Alicia; Noriega-Concepcion, Víctor; Llorente-González, Laura; Bergua-Burgues, Juan-Miguel; Lorente-de-Una, Soraya; Rodríguez-Macías, Gabriela; de-la-Fuente-Burguera, Adolfo; García-Pérez, María-José; López-Lorenzo, José-Luis; Martínez, Pilar; Alaez, Concepción; Callejas, Marta; Martínez-Chamorro, Carmen; Rifon-Roca, José; Amador-Barciela, Lourdes; Mena-Durán, Armando-V; Gómez-Correcha, Karoll; Lavilla-Rubira, Esperanza; Amigo, María-Luz; Vall-llovera, Ferrán; Garrido, Ana; García-Fortes, María; de-Miguel-Llorente, Dunia; Aules-Leonardo, Anastasia; Cervero, Carlos; Coll-Jordá, Rosa; Pérez-Encinas, Manuel-Mateo; Polo-Zarzuela, Marta; Figuera, Ángela; Rad, Guillermo; Martínez-Cuadrón, David; Montesinos, Pau (Wiley, 2023-07)
    BACKGROUND: CPX-351 is approved for the treatment of therapy related acute myeloid leukemia (t-AML) and AML with myelodysplastic related changes (MRC-AML). The benefits of this treatment over standard chemotherapy has not ...
  • SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022) 
    Capdevila-Castillon, Jaume; Alonso-Gordoa, Teresa; Carmona-Bayonas, Alberto; Custodio-Carretero, Ana; García-Carbonero, Rocío; Grande-Pulido, Enrique; Jiménez-Fonseca, Paula; Lamarca-Lete, Ángela; Segura-Huerta, Ángel; Gallego-Plazas, Javier (Springer Int Publ Ag, 2023-09)
    Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques ...
  • Biological properties of Ceraputty as a retrograde filling material: an in vitro study on hPDLSCs 
    López-García, Sergio; Rodríguez-Lozano, Francisco-Javier; Sanz, José-Luis; Forner, Leopoldo; Pecci-Lloret, María-Pilar; Lozano, Adrián; Murcia, Laura; Sánchez-Bautista, Sonia; Oñate-Sánchez, Ricardo-Elías (Springer Heidelberg, 2023-08)
    OBJECTIVES: To assess the cytocompatibility and bioactive potential of the new calcium silicate-based cement Ceraputty on human periodontal ligament stem cells (hPDLSCs) compared to Biodentine and Endosequence BC root ...
  • Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group 
    Sánchez-Cánovas, Manuel; Fernández-Garay, David; Adoamnei, Evdochia; Guirao-García, Esperanza; López-Robles, Javier; Cacho-Lavín, Diego; Martínez-de-Castro, Eva; Campos-Balea, Begoña; Garrido-Fernández, Alberto; Fernández-Pérez, Isaura; Ferrandez-Arias, Asia; Suárez, Noelia; Quintanar-Verdúguez, Teresa; Lobo-de-Mena, Miriam; Rodríguez, Laura; Gutiérrez, David; Martín-Fernández-de-Soignie, Ana-Manuela; García-Adrian, Silvia; Ferrer-Pérez, Ana-Isabel; Delgado-Heredia, María-Jesús; Muñoz-Lerma, Amelia; Luque, Raquel; Mazariegos-Rubi, Manuel; Belén-Rupérez-Blanco, Ana; García-Escobar, Ignacio; Mendiola, Jaime; Muñoz-Martín, Andrés-Jesús (Springer Int Publ Ag, 2023-10)
    PURPOSE: Both venous and arterial thrombotic events (VTE/AT) can be associated with immune checkpoint inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. METHODS/PATIENTS: ...

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta